Filament Health Announces Health Canada Approval for Phase II Trial Administering...

Psychedelic Drug Policy Reform in 2021

Psychedelics 2021: A Year in Review

The McQuade Center for Strategic Research and Development and Mindset Pharma...

Awakn Life Sciences Announces Voluntary Lock-up Agreement Extension with Management, Board...

PT281 – Oliver Grundmann, Ph.D. – A Thorough Exploration of Kratom

COMP360 psilocybin study of 89 healthy participants published in Journal of...

MHRA Guidance on the use of Real-World Data in Clinical Studies...

MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC

Psychedelic Bulletin: First Look at Field Trip’s FT-104 Molecule; MindMed Trial...

Load more